05:22:02 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Diagnos Inc (3)
Symbol ADK
Shares Issued 102,999,340
Close 2025-10-27 C$ 0.33
Market Cap C$ 33,989,782
Recent Sedar+ Documents

Diagnos appoints Charlebois to advisory board

2025-10-27 18:28 ET - News Release

Mr. Andre Larente reports

DIAGNOS WELCOMES DR. PIERRE-LUC CHARLEBOIS TO ITS ADVISORY BOARD

Dr. Pierre-Luc Charlebois has joined Diagnos Inc.'s advisory board.

Along with fellow members, Dr. Tomas J. Philipson, former vice-chairman of the White House Council of Economic Advisers, Ed Weiner, a seasoned entrepreneur, and Dr. Barry A. Ginsberg, optometrist, Dr. Charlebois will act as special counsel to the corporation's management.

Dr. Charlebois is an orthopedic surgeon practicing in the province of Quebec, Canada. Dr. Charlebois earned his orthopedic surgeon medical degree from the University of Montreal. He also holds a master's degree in health economics, policy and management from the London School of Economics and Political Science.

"I am thrilled that Pierre-Luc has accepted to join our advisory board. I am confident that his work expertise, knowledge of the Canadian health care system, as well as his business skills, will significantly contribute to Diagnos's growth," said Andre Larente, president and chief executive officer of Diagnos.

About Diagnos Inc.

Diagnos is a publicly traded Canadian corporation dedicated to early detection of critical eye-related health problems. By leveraging artificial intelligence, Diagnos aims to provide more information to health care clinicians to enhance diagnostic accuracy, streamline workflows and improve patient outcomes on a global scale.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.